Effect of different PD-1 inhibitor combination therapies for unresectable intrahepatic cholangiocarcinoma.
Zhengqing LeiWeihu MaAnfeng SiYuhua ZhangFacai YangQiushi YuHaolan TangQianru XiaoJiahua ZhouKui WangYufu TangTao HanGuowen YinJinhong ChenXiufeng LiuHua ZhaoDecai YuTao LuoQing WangMao-Lin YanXianhai MaoJing LiKai WangJingdong LiYongyi ZengDequan DingTingsong ChenXiaofeng WuYongxiang XiaKang WangWeixing GuoGuangyu ZhuShan GaoNorbert HüserWan Y LauTianqiang SongShuqun ChengFeng ShenZhangjun ChengPublished in: Alimentary pharmacology & therapeutics (2023)
Among patients with uICC, ICI-chemo or ICI-target provided more survival benefits than Chemo while achieving comparable prognoses and fewer adverse events than ICI-target-chemo.